Citations (105)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (29)
Estelle Watson, Akash Khandelwal, Jan Freijer, John van den Anker, Claudia Lefeber & Mariëlle Eerdekens. (2019) Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population. Journal of Pain Research 12, pages 2835-2850.
Read now
Read now
Christoph Beuter, Gisela Volkers, Tatjana Radic, Jutta Goldberg & John van den Anker. (2019) Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years – a randomized, double-blind, placebo-controlled trial. Journal of Pain Research 12, pages 3099-3112.
Read now
Read now
Julia C Finkel, Jutta Goldberg, Ronald Rosenburg, Jay Ariyawansa, Tao Sun, Rachel Ochs-Ross, Peter Zannikos, Liping Zhang & Mila Etropolski. (2019) First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18. Journal of Pain Research 12, pages 1925-1936.
Read now
Read now
Derek Muse, Eva Tarau, Claudia Lefeber, Melanie Sohns, Martin Brett, Jutta Goldberg & Ronald Rosenburg. (2019) Pharmacokinetics, safety, and efficacy of tapentadol oral solution for treating moderate to severe pain in pediatric patients. Journal of Pain Research 12, pages 1777-1790.
Read now
Read now
R. Ffrench-O’Carroll, H. Steinhaeuser, S. Duff, J. Close, J. McNamara, N. Ahmed, M. Murray, T. Rice & S. Immanni. (2019) A randomized controlled trial comparing tapentadol with oxycodone in non-breastfeeding women post elective cesarean section. Current Medical Research and Opinion 35:6, pages 975-981.
Read now
Read now
Laura E. Gressler, Drayton A. Hammond & Jacob T. Painter. (2017) Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research. Journal of Pain & Palliative Care Pharmacotherapy 31:3-4, pages 228-236.
Read now
Read now
Yeung-Jen Chen, Chao-Ching Chiang, Peng-Ju Huang, Jason Huang, Keith Karcher & Honglan Li. (2015) Tapentadol immediate-release for acute postbunionectomy pain: a phase 3, randomized, double-blind, placebo-controlled, parallel-group study in Taiwan. Current Medical Research and Opinion 31:11, pages 2001-2009.
Read now
Read now
Nebojsa Nick Knezevic, Tatiana Tverdohleb, Ivana Knezevic & Kenneth D Candido. (2015) Unique pharmacology of tapentadol for treating acute and chronic pain. Expert Opinion on Drug Metabolism & Toxicology 11:9, pages 1475-1492.
Read now
Read now
K. Kostev, F. Wartenberg, H. Richter, M. Reinwald & C. Heilmaier. (2015) Persistence with opioid treatment in Germany in patients suffering from chronic non-malignant or cancer pain. Current Medical Research and Opinion 31:6, pages 1157-1163.
Read now
Read now
Ashley JB MacLean & Thomas L Schwartz. (2015) Tramadol for the treatment of fibromyalgia. Expert Review of Neurotherapeutics 15:5, pages 469-475.
Read now
Read now
Neil Singla, Rachel Margulis, Kenneth Kostenbader, Yanping Zheng, Thomas Barrett, Michael J. Giuliani, Yin Chen & Jim L. Young. (2015) Randomized, double-blind, placebo-controlled study of the efficacy and safety of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen tablets for acute postoperative pain. The Physician and Sportsmedicine 43:2, pages 126-137.
Read now
Read now
Neil Singla, Thomas Barrett, Lisa Sisk, Kenneth Kostenbader & Jim Young. (2014) Assessment of the safety and efficacy of extended-release oxycodone/acetaminophen, for 14 days postsurgery. Current Medical Research and Opinion 30:12, pages 2571-2578.
Read now
Read now
Y. K. Lee, J. S. Ko, H. Y. Rhim, E. J. Lee, K. Karcher, H. Li, D. Shapiro & H. S. Lee. (2014) Acute postoperative pain relief with immediate-release tapentadol: randomized, double-blind, placebo-controlled study conducted in South Korea. Current Medical Research and Opinion 30:12, pages 2561-2570.
Read now
Read now
Johan Raeder. (2014) Opioids in the treatment of postoperative pain: old drugs with new options?. Expert Opinion on Pharmacotherapy 15:4, pages 449-452.
Read now
Read now
Neil Singla, Thomas Barrett, Lisa Sisk, Kenneth Kostenbader, Jim Young & Michael Giuliani. (2014) A randomized, double-blind, placebo-controlled study of the efficacy and safety of MNK-795, a dual-layer, biphasic, immediate-release and extended-release combination analgesic for acute pain. Current Medical Research and Opinion 30:3, pages 349-359.
Read now
Read now
Nalini Vadivelu, Yili Huang, Brian Mirante, Michael Jacoby, Ferne R Braveman, Roberta L Hines & Raymond Sinatra. (2013) Patient considerations in the use of tapentadol for moderate to severe pain. Drug, Healthcare and Patient Safety 5, pages 151-159.
Read now
Read now
Robert B Raffa, Helmut Buschmann, Thomas Christoph, Gary Eichenbaum, Werner Englberger, Christopher M Flores, Torsten Hertrampf, Babette Kögel, Klaus Schiene, Wolfgang Straßburger, Rolf Terlinden & Thomas M Tzschentke. (2012) Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opinion on Pharmacotherapy 13:10, pages 1437-1449.
Read now
Read now
Robert B Raffa, Ronald J Tallarida, Robert Taylor$suffix/text()$suffix/text() & Joseph V Pergolizzi$suffix/text()$suffix/text(). (2012) Fixed-dose combinations for emerging treatment of pain. Expert Opinion on Pharmacotherapy 13:9, pages 1261-1270.
Read now
Read now
Craig T Hartrick & Jose Rafael Rodríguez Hernandez. (2012) Tapentadol for pain: a treatment evaluation. Expert Opinion on Pharmacotherapy 13:2, pages 283-286.
Read now
Read now
Nalini Vadivelu, Alexander Timchenko, Yili Huang & Raymond Sinatra. (2011) Tapentadol extended-release for treatment of chronic pain: a review. Journal of Pain Research 4, pages 211-218.
Read now
Read now
Stephen E. Daniels, Ron J. Spivey, Sonia Singla, Michael Golf & Francis J. Clark. (2011) Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery. Current Medical Research and Opinion 27:3, pages 593-603.
Read now
Read now
Marc Afilalo, Jens-Ulrich Stegmann & David Upmalis. (2010) Tapentadol immediate release: a new treatment option for acute pain management. Journal of Pain Research 3, pages 1-9.
Read now
Read now
Robert Buynak, Douglas Y Shapiro, Akiko Okamoto, Ilse Van Hove, Christine Rauschkolb, Achim Steup, Bernd Lange, Claudia Lange & Mila Etropolski. (2010) Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study. Expert Opinion on Pharmacotherapy 11:11, pages 1787-1804.
Read now
Read now
Paul Sloan. (2010) Tapentadol for acute and chronic pain. Expert Opinion on Pharmacotherapy 11:11, pages 1783-1785.
Read now
Read now
Keith A. Candiotti & Melvin C. Gitlin. (2010) Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?. Current Medical Research and Opinion 26:7, pages 1677-1684.
Read now
Read now
Craig T Hartrick. (2010) Tapentadol immediate-release for acute pain. Expert Review of Neurotherapeutics 10:6, pages 861-869.
Read now
Read now
Craig T Hartrick. (2009) Tapentadol immediate release for the relief of moderate-to-severe acute pain. Expert Opinion on Pharmacotherapy 10:16, pages 2687-2696.
Read now
Read now
Stephen Daniels, Ed Casson, Jens-Ulrich Stegmann, Charles Oh, Akiko Okamoto, Christine Rauschkolb & David Upmalis. (2009) A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Current Medical Research and Opinion 25:6, pages 1551-1561.
Read now
Read now
Martin Hale, David Upmalis, Akiko Okamoto, Claudia Lange & Christine Rauschkolb. (2009) Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study. Current Medical Research and Opinion 25:5, pages 1095-1104.
Read now
Read now
Articles from other publishers (76)
Lorenzo Franco-de la Torre, Eduardo Gómez-Sánchez, Othoniel Hugo Aragon-Martinez, Adriana Hernández-Gómez, Diana Laura Franco-González, Juan Manuel Guzmán-Flores, Angel Josabad Alonso-Castro, Vinicio Granados-Soto & Mario Alberto Isiordia-Espinoza. (2023) Analgesic Efficacy and Safety of Tapentadol Immediate Release in Bunionectomy: A Meta-Analysis. Pharmaceuticals 16:9, pages 1287.
Crossref
Crossref
Alessandra Oliveira Silva, Danielle Aparecida de Oliveira Marrafon, Ana Flávia Amorim, Carlos Marcelo de Barros, Ricardo Radighieri Rascado, Carla Speroni Ceron, Tiago Marques dos Reis, Márcia Helena MIranda Cardoso Podestá, Daniel Augusto de Faria Almeida, Larissa Helena Torres & Marília Gabriella Alves Goulart Pereira. (2023) Tapentadol, an opioid as a strategy for the treatment of chronic pain? A narrative review. Journal of Pharmaceutical and Biological Sciences 11:1, pages 18-25.
Crossref
Crossref
S Naveen, P Elango & Ramya S. (2023) An Open-Label, Randomized, Parallel-Group Study to Assess the Safety, Efficacy, and Tolerability of Tapentadol Versus Tramadol in Outpatients with Moderate to Severe Chronic Low Back Pain at a Tertiary Care Hospital in South India. Biomedical and Pharmacology Journal 16:2, pages 1037-1046.
Crossref
Crossref
L. S. Sorokina, D. V. Fomina, M. A. Semenkova & A. A. Eremenko. (2023) Efficiency and safety of Tapentadol with immediate release for postoperative analgesia in cardiac surgery patients. Messenger of ANESTHESIOLOGY AND RESUSCITATION 20:3, pages 45-51.
Crossref
Crossref
Edward M. Rooney, Susan M. Odum, Nady Hamid, Todd A. Irwin, Todd M. ChapmanJrJr, Bruce E. Cohen, Patrick M. Connor, Brian M. Curtin, W. Hodges Davis, J. Kent Ellington, James E. Fleischli, Samuel E. Ford, R. Glenn Gaston, Kayla T. Hietpas, Carroll P. JonesIIIIII, Bryan J. Loeffler, Caleb J. Michalek, R.Alden MilamIVIV, Bryan M. Saltzman, Shadley C. Schiffern & Scott B. Shawen. (2022) Opioid-Free Forefoot Surgery vs Traditional Perioperative Opiate Regimen: A Randomized Controlled Trial. Foot & Ankle International 44:1, pages 21-31.
Crossref
Crossref
Elie SaderMDMD, Steven CalvinoMDMD & Christopher GhariboMDMD. 2022. Complications of Pain‐Relieving Procedures. Complications of Pain‐Relieving Procedures
32
37
.
Esben Bolvig Mark, Rasmus Bach Nedergaard, Tine Maria Hansen, Thomas Dahl Nissen, Jens Brøndum Frøkjær, S. Mark Scott, Klaus Krogh & Asbjørn Mohr Drewes. (2021) Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers. Neurogastroenterology & Motility 33:11.
Crossref
Crossref
Marlin Comelon, Johan Raeder, Tomas Drægni, Marit Lieng & Harald Lenz. (2021) Tapentadol versus oxycodone analgesia and side effects after laparoscopic hysterectomy. European Journal of Anaesthesiology 38:9, pages 995-1002.
Crossref
Crossref
V. V. Nikoda. (2021) Tapentadol in acute pain: a review of the results of international studies. Modern Rheumatology Journal 15:4, pages 113-119.
Crossref
Crossref
Esben Bolvig Mark, Jens Brøndum Frøkjær, Tine Maria Hansen, Rasmus Bach Nedergaard & Asbjørn Mohr Drewes. (2021) Although tapentadol and oxycodone both increase colonic volume, tapentadol treatment resulted in softer stools and less constipation: a mechanistic study in healthy volunteers. Scandinavian Journal of Pain 21:2, pages 406-414.
Crossref
Crossref
Torbjørn Rian, Eirik Skogvoll, Janne Hofstad, Lise Høvik, Siri B. Winther, Vigdis Schnell Husby, Jomar Klaksvik, Tarjei Egeberg, Kari Sand, Pål Klepstad & Tina Strømdal Wik. (2021) Tapentadol vs oxycodone for postoperative pain treatment the first 7 days after total knee arthroplasty: a randomized clinical trial. Pain 162:2, pages 396-404.
Crossref
Crossref
Bart J Morlion, César Margarit, Imane Wild, Ravi Karra, Hiltrud Liedgens, Melanie Sohns & Gabriele Finco. (2021) Bone fractures in patients using tapentadol or oxycodone: an exploratory US claims database study. Pain Management 11:1, pages 39-47.
Crossref
Crossref
Katarzyna Korwin-Kochanowska, Arnaud Potié, Kariem El-Boghdadly, Narinder Rawal, Girish Joshi & Eric Albrecht. (2020) PROSPECT guideline for hallux valgus repair surgery: a systematic review and procedure‐specific postoperative pain management recommendations. Regional Anesthesia & Pain Medicine 45:9, pages 702-708.
Crossref
Crossref
Xinyi Wang, Sujita W. Narayan, Jonathan Penm & Asad E. Patanwala. (2020) Efficacy and Safety of Tapentadol Immediate Release for Acute Pain. The Clinical Journal of Pain 36:5, pages 399-409.
Crossref
Crossref
Robert B. Raffa, Christian Elling & Thomas M. Tzschentke. (2018) Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’. Advances in Therapy 35:10, pages 1471-1484.
Crossref
Crossref
R. B. Raffa, J. V. Pergolizzi, R. Taylor & M. H. Ossipov. (2018) Nature's first “atypical opioids”: Kratom and mitragynines. Journal of Clinical Pharmacy and Therapeutics 43:3, pages 437-441.
Crossref
Crossref
Mark Holtsman & Charity Hale. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine
385
388.e1
.
Ariane Stollenwerk, Melanie Sohns, Fabian Heisig, Christian Elling & Detlef von Zabern. (2017) Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic. Advances in Therapy 35:1, pages 12-30.
Crossref
Crossref
Gertrud Haeseler, Dirk Schaefers, Natalie Prison, Jörg Ahrens, Xiaofei Liu & Annika Karch. (2017) Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone. BMC Anesthesiology 17:1.
Crossref
Crossref
Neil K. Singla, Diana S. Meske & Paul J. Desjardins. (2017) Exploring the Interplay between Rescue Drugs, Data Imputation, and Study Outcomes: Conceptual Review and Qualitative Analysis of an Acute Pain Data Set. Pain and Therapy 6:2, pages 165-175.
Crossref
Crossref
Joseph V PergolizziJrJr, Frank Breve, Robert TaylorJrJr, Robert B Raffa, Stephani E Strasburger & Jo Ann LeQuang. (2017) Considering tapentadol as a first-line analgesic: 14 questions. Pain Management 7:4, pages 331-339.
Crossref
Crossref
Nalini Vadivelu, Daniel Chang, Erik M. Helander, Gregory J. Bordelon, Alice Kai, Alan D. Kaye, Dora Hsu, Daniel Bang & Inderjeet Julka. (2017) Ketorolac, Oxymorphone, Tapentadol, and Tramadol. Anesthesiology Clinics 35:2, pages e1-e20.
Crossref
Crossref
Jing-Ping Xiao, Ai-Ling Li, Bi-Min Feng, Yun Ye & Guo-Jun Wang. (2017) Efficacy and Safety of Tapentadol Immediate Release Assessment in Treatment of Moderate to Severe Pain: A Systematic Review and Meta-Analysis. Pain Medicine 18:1, pages 14-24.
Crossref
Crossref
Eugene R. Viscusi, Lynn Webster, Michael Kuss, Stephen Daniels, James A. Bolognese, Seth Zuckerman, David G. Soergel, Ruth Ann Subach, Emily Cook & Franck Skobieranda. (2016) A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain. Pain 157:1, pages 264-272.
Crossref
Crossref
Robert Buynak, Stephen A. Rappaport, Kevin Rod, Pierre Arsenault, Fabian Heisig, Christine Rauschkolb & Mila Etropolski. (2015) Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial. Clinical Therapeutics 37:11, pages 2420-2438.
Crossref
Crossref
Karina Gritsenko, Diego Fernandez Garcia-Roves, Boleslav Kosharskyy & Naum Shaparin. (2015) Postoperative Blocks That Afford Long-Lasting Pain Relief. Topics in Pain Management 31:3, pages 1-8.
Crossref
Crossref
James A. Bolognese, Ruth Ann Subach & Franck Skobieranda. (2015) Evaluation of an Adaptive Maximizing Design Study Based on Clinical Utility Versus Morphine for TRV130 Proof-of-Concept and Dose-Regimen Finding in Patients With Postoperative Pain After Bunionectomy. Therapeutic Innovation & Regulatory Science 49:5, pages 756-766.
Crossref
Crossref
S. Ramaswamy, S. Chang & V. Mehta. (2015) Tapentadol - the evidence so far. Anaesthesia 70:5, pages 518-522.
Crossref
Crossref
Emily C. McNaughton, Ryan A. Black, Sarah E. Weber & Stephen F. Butler. (2015) Assessing Abuse Potential of New Analgesic Medications Following Market Release: An Evaluation of Internet Discussion of Tapentadol Abuse. Pain Medicine 16:1, pages 131-140.
Crossref
Crossref
Stephen F. Butler, Emily C. McNaughton & Ryan A. Black. (2015) Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse Treatment. Pain Medicine 16:1, pages 119-130.
Crossref
Crossref
Manuel J. Sánchez del Águila, Michael Schenk, Kai-Uwe Kern, Tanja Drost & Ilona Steigerwald. (2015) Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain. Clinical Therapeutics 37:1, pages 94-113.
Crossref
Crossref
Christoph Ostgathe & Bernd-Oliver Maier. 2015. Palliative Care in Oncology. Palliative Care in Oncology
59
78
.
Neil K. Singla, Paul J. Desjardins & Phoebe D. Chang. (2014) A comparison of the clinical and experimental characteristics of four acute surgical pain models: Dental extraction, bunionectomy, joint replacement, and soft tissue surgery. Pain 155:3, pages 441-456.
Crossref
Crossref
Edward Michna, Wendy Y. Cheng, Caroline Korves, Howard Birnbaum, Ryan Andrews, Zhou Zhou, Ashish V. Joshi, David Schaaf, Jack Mardekian & Mei Sheng. (2014) Systematic Literature Review and Meta-Analysis of the Efficacy and Safety of Prescription Opioids, Including Abuse-Deterrent Formulations, in Non-Cancer Pain Management. Pain Medicine 15:1, pages 79-92.
Crossref
Crossref
Howard S. Smith & Andras Laufer. (2014) Opioid induced nausea and vomiting. European Journal of Pharmacology 722, pages 67-78.
Crossref
Crossref
Mana SaraghiElliot V. Hersh. (2013) Three Newly Approved Analgesics: An Update. Anesthesia Progress 60:4, pages 178-187.
Crossref
Crossref
Timothy J. Atkinson, Jeffrey Fudin, Abhinetri Pandula & Maira Mirza. (2013) Medication Pain Management in the Elderly: Unique and Underutilized Analgesic Treatment Options. Clinical Therapeutics 35:11, pages 1669-1689.
Crossref
Crossref
Winghan J. Kwong, Geoffrey Hammond, David Upmalis, Akiko Okamoto, Min Yang & Shane Kavanagh. (2013) Bowel Function After Tapentadol and Oxycodone Immediate Release (IR) Treatment in Patients With Low Back or Osteoarthritis Pain. The Clinical Journal of Pain 29:8, pages 664-672.
Crossref
Crossref
Roy Freeman. (2013) New and Developing Drugs for the Treatment of Neuropathic Pain in Diabetes. Current Diabetes Reports 13:4, pages 500-508.
Crossref
Crossref
Gary J VorsangerJean Farrell, Jim Xiang, Wing Chow, Bruce L Moskovitz & Norman R Rosenthal. (2013) Tapentadol, oxycodone or placebo for acute pain of vertebral compression fractures: a randomized Phase IIIb study. Pain Management 3:2, pages 109-118.
Crossref
Crossref
Singaram Kathirvel, Suggala Venkata Satyanarayana & Garikapati Devalarao. (2013) Application of a Validated Stability-Indicating LC Method for the Simultaneous Estimation of Tapentadol and Its Process-Related Impurities in Bulk and Its Dosage Form. Journal of Chemistry 2013, pages 1-8.
Crossref
Crossref
Yury Khelemsky. 2013. Anesthesiology and Otolaryngology. Anesthesiology and Otolaryngology
373
391
.
S Kathirvel & K. Madhu Babu. (2012) A VALIDATED METHOD FOR THE DETERMINATION OF TAPENTADOL HYDROCHLORIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION BY DENSITOMETRIC ANALYSIS. INDIAN DRUGS 49:12, pages 51-55.
Crossref
Crossref
M. Kim & G. Vorsanger. (2012) Letter: effects of oxycodone and tapentadol dosage on gastrointestinal function. Alimentary Pharmacology & Therapeutics 36:7, pages 688-688.
Crossref
Crossref
Richard B Silverman, Keith A CandiottiMelvin C Gitlin. (2012) Tapentadol extended-release: a recent addition to our analgesic armamentarium. Pain Management 2:5, pages 451-456.
Crossref
Crossref
Shane Kavanagh, W. Jackie Kwong, Geoffrey C. Hammond, Winnie Nelson, David Upmalis & Min Yang. (2012) Pain Relief and Tolerability Balance of Immediate Release Tapentadol or Oxycodone Treatment for Patients with Moderate to Severe Osteoarthritis or Low Back Pain. Pain Medicine 13:9, pages 1110-1120.
Crossref
Crossref
Xu Steven Xu, Mila Etropolski, David Upmalis, Akiko Okamoto, Rachel Lin & Partha Nandy. (2012) Pharmacokinetic and Pharmacodynamic Modeling of Opioid-Induced Gastrointestinal Side Effects in Patients Receiving Tapentadol IR and Oxycodone IR. Pharmaceutical Research 29:9, pages 2555-2564.
Crossref
Crossref
M. Giorgi, A. Meizler & P.C. Mills. (2012) Quantification of tapentadol in canine plasma by HPLC with spectrofluorimetric detection: Development and validation of a new methodology. Journal of Pharmaceutical and Biomedical Analysis 67-68, pages 148-153.
Crossref
Crossref
I. D. Jeong, M. Camilleri, A. Shin, J. Iturrino, A. Boldingh, I. Busciglio, D. Burton, M. Ryks, D. Rhoten & A. R. Zinsmeister. (2012) A randomised, placebo‐controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Alimentary Pharmacology & Therapeutics 35:9, pages 1088-1096.
Crossref
Crossref
. (2012) Clinical Efficacy and Safety of Tapentadol Immediate Release in the Postoperative Setting. Journal of the American Podiatric Medical Association 102:2, pages 139-148.
Crossref
Crossref
Victor Mendis. (2012) Role of tapentadol in pain management. British Journal of Hospital Medicine 73:3, pages 143-147.
Crossref
Crossref
M. Merker, G. Dinges, T. Koch, P. Kranke & A.M. Morin. (2012) Unerwünschte Nebenwirkungen von Tapentadol im Vergleich zu OxycodonUndesired side effects of tapentadol in comparison to oxycodone. Der Schmerz 26:1, pages 16-26.
Crossref
Crossref
YiLi Zhou. 2012. Neurology in Clinical Practice. Neurology in Clinical Practice
783
801
.
&NA;. (2011) Tapentadol immediate- and extended-release: a guide to its use in acute and chronic pain. Drugs & Therapy Perspectives 27:12, pages 1-6.
Crossref
Crossref
Chris Pasero. (2011) Tapentadol for Multimodal Pain Management. Journal of PeriAnesthesia Nursing 26:5, pages 343-346.
Crossref
Crossref
Michael Golf, Stephen E. Daniels & Erol Onel. (2011) A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Advances in Therapy 28:9, pages 776-788.
Crossref
Crossref
Craig T. Hartrick & Richard J. Rozek. (2011) Tapentadol in Pain Management. CNS Drugs 25:5, pages 359-370.
Crossref
Crossref
Howard S. Smith & Robert L. Barkin. (2011) Fibromyalgia Syndrome: A Discussion of the Syndrome and Pharmacotherapy. Disease-a-Month 57:5, pages 248-285.
Crossref
Crossref
Mila Etropolski, Kathleen Kelly, Akiko Okamoto & Christine Rauschkolb. (2011) Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride. Advances in Therapy 28:5, pages 401-417.
Crossref
Crossref
T.M. Tzschentke, T. Christoph, W. Schröder, W. Englberger, J. De Vry, U. Jahnel & B.Y. Kögel. (2011) Tapentadol: mit zwei Mechanismen in einem Molekül wirksam gegen nozizeptive und neuropathische SchmerzenTapentadol: with two mechanisms of action in one molecule effective against nociceptive and neuropathic pain. Der Schmerz 25:1, pages 19-25.
Crossref
Crossref
Michele L Matthews & Richard Lufkin. (2011) Tapentadol: A Novel, Centrally Acting Analgesic for Moderate-to-Severe Acute Pain. Journal of Pharmacy Technology 27:1, pages 27-34.
Crossref
Crossref
Eugene R. Viscusi & Thomas A. Witkowski. (2011) Acute Pain Medicine. ASA Refresher Courses in Anesthesiology 39:1, pages 149-155.
Crossref
Crossref
Mark Holtsman & Barth L. Wilsey. 2011. Essentials of Pain Medicine. Essentials of Pain Medicine
97
100
.
Mary Lynn McPherson & Tanya J. Uritsky. 2011. Handbook of Pain Relief in Older Adults. Handbook of Pain Relief in Older Adults
83
104
.
Yvonne D'Arcy. (2010) An update on new pain medications. Nursing 40:11, pages 63-64.
Crossref
Crossref
Razmic S. GregorianJr.Jr., Alexander Gasik, Winghan Jacqueline Kwong, Simon Voeller & Shane Kavanagh. (2010) Importance of Side Effects in Opioid Treatment: A Trade-Off Analysis With Patients and Physicians. The Journal of Pain 11:11, pages 1095-1108.
Crossref
Crossref
Dan Froicu & Raymond S. Sinatra. 2010. The Essence of Analgesia and Analgesics. The Essence of Analgesia and Analgesics
143
146
.
James E. Frampton. (2010) Tapentadol Immediate Release. Drugs 70:13, pages 1719-1743.
Crossref
Crossref
James E. Wild, Stefan Grond, Brigitte Kuperwasser, Jane Gilbert, Bettyanne McCann, Bernd Lange, Achim Steup, Thomas Häufel, Mila S. Etropolski, Christine Rauschkolb & Robert Lange. (2010) Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain. Pain Practice 10:5, pages 416-427.
Crossref
Crossref
W. Jacqueline Kwong, Ipek Özer-Stillman, Jeffrey D. Miller, Noah A. Haber, Mason W. Russell & Shane Kavanagh. (2010) Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain. Clinical Therapeutics 32:10, pages 1768-1781.
Crossref
Crossref
Howard S Smith & Robert L Barkin. (2010) Fibromyalgia Syndrome: A Discussion of the Syndrome and Pharmacotherapy. American Journal of Therapeutics 17:4, pages 418-439.
Crossref
Crossref
Bart Morlion, Joseph V. PergolizziJrJr & Robert B. Raffa. (2010) European perspectives on upcoming analgesics: What do they have that we don't—and what do they think about them?. Techniques in Regional Anesthesia and Pain Management 14:2, pages 86-98.
Crossref
Crossref
Giustino Varrassi, Franco Marinangeli, Alba Piroli, Stefano Coaccioli & Antonella Paladini. (2010) Strong analgesics: Working towards an optimal balance between efficacy and side effects. European Journal of Pain 14:4, pages 340-342.
Crossref
Crossref
Clifford Gevirtz. (2010) A Comparative Analysis of Tapentadol, Tramadol, and the Opiates. Topics in Pain Management 25:8, pages 1-7.
Crossref
Crossref
Thomas Christoph, Jean De Vry & Thomas M. Tzschentke. (2010) Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Neuroscience Letters 470:2, pages 91-94.
Crossref
Crossref
Johan W Smit, Charles Oh, Jens Rengelshausen, Rolf Terlinden, Paulien G. M Ravenstijn, Shean-Sheng Wang, David Upmalis & Bernhard Mangold. (2010) Effects of Acetaminophen, Naproxen, and Acetylsalicylic Acid on Tapentadol Pharmacokinetics: Results of Two Randomized, Open-Label, Crossover, Drug-Drug Interaction Studies. Pharmacotherapy 30:1, pages 25-34.
Crossref
Crossref